Darling Ingredients Revenue and Competitors

Dallas, TX USA

Location

$2.9B

Total Funding

Estimated Revenue & Valuation

  • Darling Ingredients's estimated annual revenue is currently $4.5B per year.(i)
  • Darling Ingredients's estimated revenue per employee is $2,206,247
  • Darling Ingredients's total funding is $2.9B.
  • Darling Ingredients's current valuation is $10.6B. (January 2022)

Employee Data

  • Darling Ingredients has 2017 Employees.(i)
  • Darling Ingredients grew their employee count by 10% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$7.8M4932%N/AN/A
#2
$16M7633%N/AN/A
#3
$1.4M1110%N/AN/A
#4
$4450M201710%$2.9BN/A
#5
$99.2M378-5%N/AN/A
#6
$1.5M12-8%N/AN/A
#7
$116.8M4458%N/AN/A
#8
$1.4M11-8%N/AN/A
#9
$8.2M499%N/AN/A
#10
$28.1M13411%N/AN/A
Add Company

Darling International Inc provides recycling and rendering services in which animal and food waste products are turned into useful commercial goods, including tallow, protein meals (Meat and Bone Meal), and yellow grease. Darling also services the restaurant industry by removing used cooking oil and pumping grease traps.

keywords:N/A

$2.9B

Total Funding

2017

Number of Employees

$4.5B

Revenue (est)

10%

Employee Growth %

$10.6B

Valuation

N/A

Accelerator

Darling Ingredients News

2022-04-20 - Marine Collagen Market Size, Scope And Forecast | Ashland ...

Ashland, Darling Ingredients, Nitta Gelatin, Gelila, Weishardt Group, Amicogen, Nippi Incorporated, Seagarden, Chinapeptide, Vital Proteins.

2022-04-17 - Darling Ingredients (NYSE:DAR) Rating Lowered to Hold at ...

Darling Ingredients (NYSE:DAR) Rating Lowered to Hold at Zacks Investment Research. Posted by admin on Apr 22nd, 2022.

2022-04-13 - Rousselot® Biomedical, Darling Ingredients' brand ...

X-Pure® GelMA is the first gelatin methacryloyl, or GelMA, on the market to be produced under GMP conditions2. Rousselot®...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$414.9M2044N/AN/A
#2
$1014.6M215427%N/A
#3
$974.3M2168-11%N/A
#4
$542.9M221611%N/A
#5
$914.3M225212%N/A